EBOS Group (NZSE:EBO) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

EBO Overzicht aandelen

EBOS Group Limited houdt zich bezig met de marketing, groothandel en distributie van producten voor de gezondheidszorg, medische en farmaceutische producten en producten voor dierverzorging in Australië, Zuidoost-Azië en Nieuw-Zeeland.

Over het bedrijf

EBO fundamentele analyse
Sneeuwvlok Score
Waardering	3/6
Toekomstige groei	1/6
Prestaties in het verleden	2/6
Financiële gezondheid	3/6
Dividenden	4/6

Beloningen

Verhandeld tegen 22.1% onder onze schatting van de reële waarde

De winst zal naar verwachting met 6.93% per jaar groeien

De winst is de afgelopen 5 jaar met 13.5% per jaar gegroeid

Risicoanalyse

Heeft een hoog schuldenniveau

Dividend van 3.41% wordt niet goed gedekt door vrije kasstromen

EBOS Group Limited Concurrenten

Summerset Group Holdings

NZSE:SUM

NZ$2.8b

Arvida Group

NZSE:ARV

NZ$1.2b

Fisher & Paykel Healthcare

NZSE:FPH

NZ$21.1b

Jointown Pharmaceutical Group

SHSE:600998

CN¥28.2b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor EBOS Group
Historische aandelenkoersen
Huidige aandelenkoers	NZ$36.90
52 Week Hoogtepunt	NZ$38.60
52 Week Laag	NZ$31.02
Bèta	0.26
11 maand verandering	4.00%
3 maanden verandering	15.17%
1 Jaar Verandering	5.13%
33 jaar verandering	6.80%
5 jaar verandering	50.61%
Verandering sinds IPO	1,526.02%

Recent nieuws en updates

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Sep 29

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Sep 15

Recent updates

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Sep 29

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Sep 15

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

Feb 23

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

Jan 23

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Dec 18

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Nov 02

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

Oct 17

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

Oct 02

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Aug 02

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Jun 26

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

May 02

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Apr 14

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

Mar 14

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 26

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jan 06

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Nov 28

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

Oct 21

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

Oct 05

Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?

Sep 13

EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116

Aug 26

Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement

Jun 24

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued

May 10

Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

Mar 17

We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings

Feb 26

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 18

EBOS Group Limited's (NZSE:EBO) Intrinsic Value Is Potentially 41% Above Its Share Price

Jan 22

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Dec 26

EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger

Oct 31

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 23% Undervalued

Oct 18

Is EBOS Group (NZSE:EBO) A Risky Investment?

Sep 19

Here's Why I Think EBOS Group (NZSE:EBO) Might Deserve Your Attention Today

Aug 05

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jul 13

EBOS Group's (NZSE:EBO) Returns Have Hit A Wall

Jun 09

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

May 01

Here's Why EBOS Group (NZSE:EBO) Can Manage Its Debt Responsibly

Apr 08

A Look At The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Mar 27

Is EBOS Group Limited's (NZSE:EBO) Recent Performance Tethered To Its Attractive Financial Prospects?

Mar 15

Is EBOS Group Limited (NZSE:EBO) A Smart Pick For Income Investors?

Mar 03

Analysts Are Updating Their EBOS Group Limited (NZSE:EBO) Estimates After Its Half-Year Results

Feb 19

Rendement voor aandeelhouders

	EBO	NZ Healthcare	NZ Markt
7D	2.9%	0.5%	0.3%
1Y	5.1%	0.03%	6.3%

Rendement versus industrie: EBO overtrof de NZ Healthcare industrie, die het afgelopen jaar een rendement -2.5 % opleverde.

Rendement versus markt: EBO presteerde slechter dan NZ Market, dat het afgelopen jaar een rendement van 6.3 % opleverde.

Prijsvolatiliteit

Is EBO's price volatile compared to industry and market?
EBO volatility
EBO Average Weekly Movement	3.0%
Healthcare Industry Average Movement	5.3%
Market Average Movement	4.6%
10% most volatile stocks in NZ Market	10.1%
10% least volatile stocks in NZ Market	3.1%

Stabiele aandelenkoers: EBO heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van EBO is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1922	4,557	John Cullity	www.ebosgroup.com

EBOS Group Limited houdt zich bezig met de marketing, groothandel en distributie van medische, farmaceutische en dierverzorgingsproducten in Australië, Zuidoost-Azië en Nieuw-Zeeland. Het bedrijf opereert via de segmenten Gezondheidszorg en Dierverzorging. Het bedrijf biedt gezondheidszorglogistiek, medicatiebeheeroplossingen, software voor apotheekbeheer, diensten op het gebied van loyaliteit, generieke geneesmiddelen, naleving, bedrijfsintelligentie en winkelsoftware, en diensten op het gebied van gezondheidscommunicatie, -programma's en -advies.

EBOS Group Limited Samenvatting

Hoe verhouden de winst en inkomsten van EBOS Group zich tot de beurswaarde?
EBO fundamentele statistieken
Marktkapitalisatie	NZ$7.18b
Inkomsten(TTM)	NZ$299.55m
Inkomsten(TTM)	NZ$14.55b

24.0x

Koers/Winstverhouding

0.5x

P/S-verhouding

Is EBO overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
EBO resultatenrekening (TTM)
Inkomsten	AU$13.19b
Kosten van inkomsten	AU$11.56b
Brutowinst	AU$1.63b
Overige uitgaven	AU$1.36b
Inkomsten	AU$271.55m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	1.39
Brutomarge	12.38%
Nettowinstmarge	2.06%
Schuld/Eigen Vermogen Verhouding	51.1%

Hoe presteerde EBO op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

3.4%

Huidig dividendrendement

78%

Uitbetalingsratio

EBO Overzicht aandelen

Beloningen

Risicoanalyse

EBOS Group Limited Concurrenten

NZSE:SUM

NZ$2.8b

NZSE:ARV

NZ$1.2b

NZSE:FPH

NZ$21.1b

SHSE:600998

CN¥28.2b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Final dividend of NZ$0.64 announced

EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Final dividend of NZ$0.64 announced

EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Earnings Not Telling The Story For EBOS Group Limited (NZSE:EBO)

Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

EBOS Group Limited Announces Chief Financial Officer Changes

EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly

Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E

Insider recently sold NZ$5.3m worth of stock

EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951

First half dividend of NZ$0.60 announced

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

First half 2024 earnings released: EPS: AU$0.71 (vs AU$0.70 in 1H 2023)

EBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

Now 21% undervalued

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024

Now 21% undervalued

EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million.

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk

Now 22% undervalued after recent price drop

EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit

EBOS Not to Proceed with Acquisition in Animal Care Segment

EBOS Not to Proceed with Acquisition in Animal Care Segment

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023

Now 20% undervalued

Upcoming dividend of NZ$0.60 per share at 3.0% yield

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Ebos Group Limited Announces Dividend, Payable on 29 September 2023

Full year 2023 earnings: EPS misses analyst expectations

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued after recent price drop

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

First half 2023 earnings released: EPS: AU$0.70 (vs AU$0.61 in 1H 2022)

EBOS Group Limited to Report Q2, 2023 Results on Feb 22, 2023

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022

Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?

Upcoming dividend of NZ$0.51 per share

EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

EBOS Group Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 30 September, 2022